Page last updated: 2024-11-04

spiperone and Narcolepsy

spiperone has been researched along with Narcolepsy in 1 studies

Spiperone: A spiro butyrophenone analog similar to HALOPERIDOL and other related compounds. It has been recommended in the treatment of SCHIZOPHRENIA.
spiperone : An azaspiro compound that is 1,3,8-triazaspiro[4.5]decane which is substituted at positions 1, 4, and 8 by phenyl, oxo, and 4-(p-fluorophenyl)-4-oxobutyl groups, respectively.

Narcolepsy: A condition characterized by recurrent episodes of daytime somnolence and lapses in consciousness (microsomnias) that may be associated with automatic behaviors and AMNESIA. CATAPLEXY; SLEEP PARALYSIS, and hypnagogic HALLUCINATIONS frequently accompany narcolepsy. The pathophysiology of this disorder includes sleep-onset rapid eye movement (REM) sleep, which normally follows stage III or IV sleep. (From Neurology 1998 Feb;50(2 Suppl 1):S2-S7)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
MacFarlane, JG1
List, SJ1
Moldofsky, H1
Firnau, G1
Chen, JJ1
Szechtman, H1
Garnett, S1
Nahmias, C1

Trials

1 trial available for spiperone and Narcolepsy

ArticleYear
Dopamine D2 receptors quantified in vivo in human narcolepsy.
    Biological psychiatry, 1997, Feb-01, Volume: 41, Issue:3

    Topics: Adolescent; Adult; Cerebrovascular Circulation; Female; Humans; Ligands; Male; Narcolepsy; Neostriat

1997